Evidence map›Paper›PMID 37781604›Full record

ArticlebioRxiv : the preprint server for biology2023

GammaGateR: semi-automated marker gating for single-cell multiplexed imaging.

Jiangmei Xiong, Harsimran Kaur, Cody N Heiser, Eliot T McKinley, Joseph T Roland, Robert J Coffey, Martha J Shrubsole, Julia Wrobel, Siyuan Ma, Ken S Lau and 1 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Jiangmei XiongDepartment of Biostatistics, Vanderbilt University, USA.
Harsimran KaurProgram of Chemical and Physical Biology, Vanderbilt University School of Medicine, USA.
Cody N HeiserProgram of Chemical and Physical Biology, Vanderbilt University School of Medicine, USA.
Eliot T McKinleyEpithelial Biology Center, Vanderbilt University Medical Center, USA.
Joseph T RolandEpithelial Biology Center, Vanderbilt University Medical Center, USA.
Robert J CoffeyEpithelial Biology Center, Vanderbilt University Medical Center, USA.
Martha J ShrubsoleDepartment of Medicine, Vanderbilt University Medical Center, USA.
Julia WrobelDepartment of Biostatistics and Bioinformatics, Emory University, USA.
Siyuan MaDepartment of Biostatistics, Vanderbilt University, USA.
Ken S LauProgram of Chemical and Physical Biology, Vanderbilt University School of Medicine, USA.
Simon VandekarDepartment of Biostatistics, Vanderbilt University, USA.
Vanderbilt University · USVanderbilt University Medical Center · USEmory University · USGlaxoSmithKline (United States) · USRegeneron (United States) · US

Funding

Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal CancerP50CA236733 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STEPHEN W. FESIK · 2019 to 2026
$19.6M
Molecular, Cellular and Tissue Characterization UnitU2CCA233291 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI COFFEY, ROBERT J. · 2018 to 2023
$12.2M
Shaping the Microenvironment by DPEP1 Facilitates Adenoma ProgressionU54CA274367 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Bhuminder Singh · 2022 to 2026
$9.7M
Integrated approach to study early and late events in colonic neoplasia: mouse to manR35CA197570 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Robert J. Coffey · 2017 to 2026
$9.4M
Tuft cell heterogeneity in function, lineage, and structure in ileal inflammatory diseaseR01DK103831 · NIDDK · VANDERBILT UNIVERSITY · PI LAU, KEN S · 2016 to 2024
$4.4M
NCI NIH HHS P50 CA236733NCI NIH HHS R35 CA197570NCI NIH HHS U2C CA233291NCI NIH HHS U54 CA274367NIDDK NIH HHS P30 DK058404NIDDK NIH HHS R01 DK103831
6 · The paper itself

Abstract

Motivation: Multiplexed immunofluorescence (mIF) is an emerging assay for multichannel protein imaging that can decipher cell-level spatial features in tissues. However, existing automated cell phenotyping methods, such as clustering, face challenges in achieving consistency across experiments and often require subjective evaluation. As a result, mIF analyses often revert to marker gating based on manual thresholding of raw imaging data. Results: To address the need for an evaluable semi-automated algorithm, we developed GammaGateR, an R package for interactive marker gating designed specifically for segmented cell-level data from mIF images. Based on a novel closed-form gamma mixture model, GammaGateR provides estimates of marker-positive cell proportions and soft clustering of marker-positive cells. The model incorporates user-specified constraints that provide a consistent but slide-specific model fit. We compared GammaGateR against the newest unsupervised approach for annotating mIF data, employing two colon datasets and one ovarian cancer dataset for the evaluation. We showed that GammaGateR produces highly similar results to a silver standard established through manual annotation. Furthermore, we demonstrated its effectiveness in identifying biological signals, achieved by mapping known spatial interactions between CD68 and MUC5AC cells in the colon and by accurately predicting survival in ovarian cancer patients using the phenotype probabilities as input for machine learning methods. GammaGateR is a highly efficient tool that can improve the replicability of marker gating results, while reducing the time of manual segmentation. Availability and Implementation: The R package is available at https://github.com/JiangmeiRubyXiong/GammaGateR.

Indexed as

classificationCODEXCyCIFmixture modelmxIFPhenotyping

Identifiers

PMID37781604
PMCPMC10541135
OpenAlexW4386985479

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.